Lung Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Lung Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Mar 28, 2018

---

• Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.  
  Lindquist Kajsa Ericson et al. Oncotarget 2017 May 8(21) 34796-34810
• Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.  
  Liao Wei-Yu et al. Lung cancer (Amsterdam, Netherlands) 2018 Apr 11890-96
• How Scientists are Looking to Expand the Benefits of Immunotherapy  
  Dana Farber Blog, Mar 22, 2018
• Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01).  
  Ku Bo Mi et al. Journal of pathology and translational medicine 2018 Mar
• The Emotional Toll of Post-Diagnosis Genetic Testing  
  W Baer, WebMD Blog, Mar 2018
• Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.  
  Dankner Matthew et al. Oncogene 2018 Mar
• CMS Announces Decision to Cover Genomic Testing for Patients With Cancer,  
  by Tony Hagen, Target Oncology, March 20, 2018
• Cost-effectiveness of KRAS , EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.  
  Loubière Sandrine et al. The European respiratory journal 2018 Mar 51(3)
• Translation of knowledge to practice - Improving awareness in NSCLC molecular testing.  
  Zer Alona et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Mar
• Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.  
  Lynch Julie A et al. BMC cancer 2018 Mar 18(1) 306